Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

Merck obtains rights to experimental Ebola vaccine

marketwatch.com — Merck & Co. has obtained the rights to an experimental Ebola vaccine developed by NewLink Genetics Corp., another sign of the scramble by pharmaceutical companies and other groups to find new ways to combat the deadly viral outbreak centered in West Africa.

New Bristol-Myers Drug Helped Skin-Cancer Patients in Trial Live Longer

online.wsj.com — A new Bristol-Myers Squibb Co. drug helped skin-cancer patients live longer than those who received chemotherapy in a clinical trial, the latest evidence behind a promising new crop of drugs that work by unleashing the body's immune system against tumors.

Researchers to Start Studies of Two Antivirals in Ebola Patients in December

online.wsj.com — Researchers plan to start clinical trials in West Africa in December to test whether two antiviral drugs can help patients survive the deadly Ebola virus, and hope to get answers by February 2015.

Merck Filing Suggests Trial Results Won’t Significantly Hurt Vytorin, Zetia

online.wsj.com — Merck & Co. said Monday it has learned the results of a long-running clinical trial designed to answer questions about the efficacy of blockbuster cholesterol drugs Vytorin and Zetia and has determined there is no need to write down their value for accounting purposes.

Race Is On to Detect Ebola More Quickly

online.wsj.com — Kirk Ririe boarded a flight from Salt Lake City to New York on Oct. 25 with an unusual item checked into his baggage: a machine that can test whether people are infected with Ebola virus.

USA und Europa liefern sich Glaubenskrieg um Ebola-Therapie

wsj.de — Europa und die USA streiten sich, welche Behandlung angesichts der Ebola-Epidemie ethisch vertretbar und wirksam ist. Eine Gruppe aus europäischen Universitäten und medizinischen Verbänden plant, west-afrikanischen Ebola-Patienten experimentelle Medikamente zu verabreichen - ohne Kontrollgruppe. Die USA halten davon wenig.

Europeans’ Plan to do Uncontrolled Ebola Trial Draws Fire

online.wsj.com — Medical groups in the U.K. and France say that it would be unethical to hold back experimental Ebola treatments from anyone. U.S. officials say that without control groups getting placebos, it can't be known whether the drugs are saving lives or killing people.

Judge Slashes Damages Takeda, Lilly to Pay in Actos Case to $38.1 Million

online.wsj.com — A U.S. judge slashed the amount of damages that drug makers Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay in a product-liability case to $38.1 million from the more than $9 billion awarded by a jury earlier this year.

Flu-Shot Supply Dented by Production Woes

online.wsj.com — Some influenza-vaccine makers have delayed shipments to U.S. doctors and pharmacies because of production problems, forcing some health-care providers to put off vaccinations as flu season gets under way. The U.S. Centers for Disease Control and Prevention says there have been delays in shipments-from big manufacturers including GlaxoSmithKline PLC and Sanofi SA-that were originally anticipated for August and September.

Study to Look at Blood Products From Ebola Survivors as Treatment

online.wsj.com — Researchers plan to test the effectiveness of transfusing blood products from Ebola survivors into infected patients, as a potential near-term countermeasure to the outbreak in West Africa.
More Articles →
Nov 25, 2014

Basal cells are the most common form of cancer, but rarely fatal. New drugs have emerged for advanced cases: on.wsj.com/1y9sUz8 via @WSJ

Nov 25, 2014

RT @ArmstrongDrew: Here's what happened to cancer drug costs since 1975. (Massive caveat -- cancer drugs have improved since 1975) pic.twitter.com/olqMK1VLfm

Nov 25, 2014

RT @jon_kamp: After year of public debate about common uterine surgery tool, FDA issues new warning on #morcellators on.wsj.com/1Fjqlg1 via @WSJ

Nov 25, 2014

RT @stefaniei: The other skin cancer: Basal cell carcinoma is rarely fatal but likely rising. A look at treatments. on.wsj.com/1y9sUz8 @loftus

Nov 25, 2014

RT @JeanneWhalen: Merck obtains rights to experimental Ebola vaccine developed by NewLink Genetics. $MRK on.wsj.com/1y8bUJE by @loftus

Nov 20, 2014

RT @krystadawn: Stunned that I can't get a flu shot for my daughter. Not at pediatrician or any pharmacy in Irvine. AHHHH!

Nov 20, 2014

RT @jonathanrockoff: They agreed to buy $AGN but Ackman & Pearson disagreed abt much else, incl $VRX guidance. on.wsj.com/1xQBBNu @Dav…

Nov 20, 2014

RT @JeanneWhalen: Double mastectomy rates rise among women with early-stage breast cancer. on.wsj.com/1xE9bsI via @WSJ

Nov 20, 2014

'It’s still true that we as a community have a poor track record for sharing the results of clinical trials' on.wsj.com/14NTcw5 via @WSJ

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.

Share This Profile